TREK-1, a K+ channel involved in neuroprotection and general anesthesia

EMBO Journal

Volumn 23, Issue 13, 2004, Pages 2684-2695

  Heurteaux, C ^a   Guy, N ^a   Laigle, C ^a   Blondeau, N ^a   Duprat, F ^a   Mazzuca, M ^a   Lang Lazdunski, L ^a   Widmann, C ^a   Zanzouri, M ^a   Romey, G ^a   Lazdunski, M ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

2P domain K+ channel; Epilepsy; Ischemia; Neuroprotection; Volatile anesthetics

Indexed keywords

CELL MEMBRANE PROTEIN; INHALATION ANESTHETIC AGENT; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; PROTEIN TREK 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL PROTECTION; CONTROLLED STUDY; EPILEPSY; GENERAL ANESTHESIA; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD ISCHEMIA;

ANESTHESIA, GENERAL; ANESTHETICS, GENERAL; ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; EPILEPSY; FATTY ACIDS, UNSATURATED; GENE DELETION; GENE EXPRESSION; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HETEROZYGOTE; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING; LYSOPHOSPHOLIPIDS; MICE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD ISCHEMIA;

ANIMALIA;

EID: 3342981356     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.emboj.7600234     Document Type: Article

References (54)

1. Blondeau N, Lauritzen I, Widmann C, Lazdunski M, Heurteaux C (2002) A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures. J Cereb Blood Flow Metab 22: 821-834
2. Blondeau N, Widmann C, Lazdunski M, Heurteaux C (2001) Polyunsaturated fatty acids induce ischemic and epileptic tolerance. Neuroscience 109: 231-241
3. Bockaert J, Pin J, Fagni L (1993) Metabotropic glutamate receptors: an original family of G protein-coupled receptors. Fund Clin Pharmacol 7: 473-485
4. Bordi F, Ugolini A (1999) Group I metabotropic glutamate receptors: implications for brain diseases. Prog Neurobiol 59: 55-79
5. Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M (2001) Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409: 88-92
6. Campagna JA, Miller KW, Forman SA (2003) Mechanisms of actions of inhaled anesthetics. N Engl J Med 348: 2110-2124
7. + channels. EMBO J 22: 1-9
8. Duprat F, Lesage F, Patel AJ, Fink M, Romey G, Lazdunski M (2000) The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK. Mol Pharmacol 57: 906-912
9. Ettaiche M, Fillacier K, Widman C, Heurteaux C, Lazdunski M (1999) Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci 40: 729-736
10. 2+ stores and ion channels in neurons. Trends Neurosci 23: 80-88
11. + channel. EMBO J 15: 6854-6862
12. + channel stimulated by arachidonic acid and polyunsaturated fatty acid. EMBO J 17: 3297-3308
13. Gasparini F, Kuhn R, Pin JP (2002) Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2: 43-49
14. Hervieu GJ, Cluderay JE, Gray CW, Green PJ, Ranson JL, Randall AD, Meadows HJ (2001) Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS. Neuroscience 103: 899-919
15. Jan LY, Jan YN (1997) Cloned potassium channels from eukaryotes and prokaryotes. Annu Rev Neurosci 20: 91-123
16. + channels in cultured rat neuronal cells. J Physiol 484: 643-660
17. Kita H, Kitai ST (1988) Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res 447: 346-352
18. Kouchoukos NT, Dougenis D (1997) Surgery of the thoracic aorta. N Engl J Med 336: 1876-1888
19. Kurachi Y, Jan LY, Lazdunski M (1999) Potassium ion channels. Molecular structure, function, and diseases. In Current Topics in Membranes, Kurachi Y, Jan LY, Lazdunski M (eds) Vol. 46. San Diego, CA: Academic Press
20. Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C (2003) Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg 38: 564-575
21. Lang-Lazdunski L, Heurteaux C, Vaillant C, Widman C, Lazdunski M (1999) Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 117: 881-889
22. Lang-Lazdunski L, Matsushita K, Hirt L, Waeber C, Vonsattel JP, Moskowitz MA, Dietrich WD (2000) Spinal cord ischemia. Development of a model in the mouse. Stroke 31: 208-213
23. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M (2000) Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 19: 1784-1793
24. Leaf A, Kang JX (1996) Prevention of cardiac sudden death by N-3 fatty acids: a review of the evidence. J Intern Med 240: 5-12
25. Leaf A, Kang JX, Xiao Y-F, Billman GE, Voskuyl RA (1999) The antiarrhythmic and anticonvulsant effects of dietary N-3 fatty acids. J Membr Biol 172: 1-11
26. Lesage F (2003) Pharmacology of neuronal background potassium channels. Neuropharmacology 44: 1-7
27. Lesage F, Lazdunski M (2000) Molecular and functional properties of two pore domain potassium channels. Am J Physiol 279: 793-801
28. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem 275: 28398-28405
29. + channel. J Biol Chem 274: 1381-1387
30. Maingret F, Lauritzen I, Patel AJ, Heurteaux C, Reyes R, Lesage F, Lazdunski M, Honoré E (2000a) TREK-1 is a heat-activated background K(+) channel. EMBO J 19: 2483-2491
31. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honoré E (1999b) Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem 274: 26691-26696
32. + channels TREK-1 and TRAAK. J Biol Chem 275: 10128-10133
33. Nair SS, Leitch JW, Falconer J, Garg ML (1997) Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 127: 383-393
34. Nicoletti F, Bruno V, Copani A, Casabona G, Knopfel T (1996) Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci 19: 267-271
35. Nordoy A (1999) Dietary fatty acids and coronary heart disease. Lipids 34: S19-S22
36. + channels. Trends Neurosci 24: 339-346
37. + channels. Nat Neurosci 2: 422-426
38. + channel. EMBO J 17: 4283-4290
39. Pongs O (1999) Voltage-gated potassium channels: from hyperexcitability to excitement. FEBS Lett 452: 31-35
40. Pratt J, Rataud J, Bardot F, Roux M, Blanchard JC, Laduron PM, Stutzmann JM (1992) Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci Lett 140: 225-230
41. Quasha AL, Eger EI, Tinker JH (1980) Determination and applications of MAC. Anesthesiology 53: 315-334
42. + channels conserved in flies, mice and humans. Trends Neurosci 15: 161-166
43. Sheng H, Laskowitz DT, Pearlstein RD, Warner DS (1999) Characterization of a recovery global cerebral ischemia model in the mouse. J Neurosci Methods 88: 103-109
44. + channels in Aplysia sensory neurones. Nature 299: 413-417
45. Smeyne RJ, Schilling K, Robertson L, Luk D, Oberdick J, Curran T, Morgan JI (1992) fos-lacZ transgenic mice: mapping sites of gene induction in the central nervous system. Neuron 8: 13-23
46. Stoll AL, Severus E, Freeman MP, Rueter S, Zboyan HA, Diamond E, Gress KK, Marangell LB (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry ,56: 413-416
47. Talley EM, Sirois JE, Lei Q, Bayliss DA (2003) Two-pore-domain (KCNK) potassium channels: dynamic roles in neuronal function. Neuroscientist 9: 46-56
48. Talley EM, Solorzano G, Lei Q, Kim D, Bayliss DA (2001) CNS distribution of members of the two-pore-domain (KCNK) potassium channel family. J Neurosci 21: 7491-7505
49. Treiman DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42: 8-12
50. Tsirka SE, Gualandris A, Amaral DG, Strickland S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377: 340-344
51. Wang J (2003) Short-term cerebral ischemia causes the dysfunction of interneurons and more excitation of pyramidal neurons in rats. Brain Res Bull 60: 53-58
52. Wei A, Jegla T, Salkoff L (1996) Eight potassium channel families revealed by the C. elegans genome project. Neuropharmacology 35: 805-829
53. Weiss S, Pin JP, Sebben M, Kemp DE, Sladeczek F, Gabrion J, Bockaert J (1986) Synaptogenesis of cultured striatal neurons in serum-free medium: a morphological and biochemical study. Proc Natl Acad Sci USA 83: 2238-2242
54. Yamakura T, Bertaccini E, Trudell JR, Harris RA (2001) Anesthetics and ion channels: molecular models and sites of action. Annu Rev Pharmacol Toxicol 41: 23-51